Access in Abu Dhabi, UAE

Middle East ยท Tier 1

Regulatory framework

Abu Dhabi runs the emirate-level Named Patient / compassionate-use pathway through Department of Health Abu Dhabi (DoH), coordinated with the federal Ministry of Health and Prevention (MoHAP) where required. Abu Dhabi-licensed physicians apply on behalf of individual patients for drugs not registered in-country or not stocked at the dispensing facility. Tertiary hospitals such as Cleveland Clinic Abu Dhabi, Sheikh Khalifa Medical City, and NMC Royal Hospital use this workflow routinely.

Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.

Typical timeline

For patients in Abu Dhabi requesting a specialty drug through Reserve Meds, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

  1. Patient or physician submits a request with drug name and indication.
  2. We verify clinical appropriateness and document eligibility.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific regulatory documentation is prepared and submitted.
  5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
  6. Drug ships cold-chain to destination physician or hospital pharmacy.
  7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from Abu Dhabi

Lenmeldy

Metachromatic leukodystrophy

Kresladi

Leukocyte adhesion deficiency I

Elevidys

Duchenne muscular dystrophy

Lyfgenia

Sickle cell disease

Zevaskyn

Recessive DEB

Skysona

Cerebral adrenoleukodystrophy

Casgevy

Sickle cell disease; transfusion-dependent beta-thalassemia

Ryoncil

Pediatric SR-aGvHD

Tecelra

Synovial sarcoma

Encelto

Macular telangiectasia type 2

Qfitlia

Hemophilia A/B prophylaxis

Vyjuvek

Dystrophic epidermolysis bullosa

WhatsApp